SpringWorks Therapeutics' Stock Jumps After FDA Approves First Treatment for Rare Type of Aggressive Tumors
SpringWorks Therapeutics' Stock Jumps After FDA Approves First Treatment for Rare Type of Aggressive Tumors
美國食品藥品管理局批准第一種罕見侵襲性腫瘤的治療方法後，SpringWorks Therapeutics的股票上漲
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊